How Asbestos Trust Fund Payment Percentages Are Calculated: 4 Key Factors

Asbestos trust funds pay claimants anywhere from 5.1% to 100% of the scheduled disease value—a range so wide it leaves most patients confused about what they'll actually receive. The payment percentage at any given trust is calculated by actuaries using four primary factors: the trust's remaining assets, projected future claims volume, historical claims experience, and investment return assumptions. Understanding how these factors interact determines whether your claim yields thousands or hundreds of thousands of dollars from a single trust.

What Are the Key Facts About Asbestos Trust Fund Payment Percentages?

• Payment percentages range from 5.1% (Johns-Manville Trust) to 100% at smaller trusts with fewer projected future claims
• Each trust hires independent actuaries to project total claims volume over the life of the fund and set a sustainable payment rate
• The payment percentage is applied to the "scheduled value"—a fixed compensation amount assigned to each disease category in the Trust Distribution Procedure (TDP)
• Mesothelioma typically carries the highest scheduled value of any disease category at most trusts, often ranging from $100,000 to $1.2 million depending on the specific trust
• Payment percentages can be reduced over time if actual claims exceed projections or investment returns fall short; increases are less common but do occur
• The GAO has documented over 60 active asbestos bankruptcy trusts as of the most recent federal audit, with combined assets exceeding $30 billion
• Individual review claims (as opposed to expedited review) allow claimants to request above-scheduled-value payments based on exceptional exposure or occupational history
• Most mesothelioma patients qualify for 5 to 10 or more simultaneous trust fund claims, multiplying the impact of even low individual payment percentages
• Section 524(g) of the Bankruptcy Code governs the creation and operation of asbestos trust funds to ensure all claimants are treated equitably
• Trust fund claims and personal injury lawsuits can be pursued simultaneously—trusts do not offset lawsuit settlements in most jurisdictions

What Is a Scheduled Value and How Is It Set?

Every asbestos trust fund operates under a Trust Distribution Procedure (TDP) that assigns a scheduled value—a baseline dollar amount—to each recognized disease category. The scheduled value represents what the trust would pay at a 100% payment percentage, before the trust's current payment rate is applied.

Disease categories in most TDPs include: mesothelioma (highest scheduled value), lung cancer with asbestosis, lung cancer without asbestosis (requires occupational exposure evidence), other cancer, asbestosis, pleural disease with functional impairment, and pleural disease without functional impairment. Mesothelioma's scheduled value at the Johns-Manville Trust is approximately $1.2 million. At a 5.1% payment percentage, the actual payment is approximately $61,200—before adjustments for expedited versus individual review.

According to the Asbestos Trust Funds overview at WikiMesothelioma, the combined $30 billion in trust reserves spans over 60 active funds, each with different scheduled values reflecting the volume and severity of claims that specific company's products generated. Trusts tied to manufacturers with widespread residential product exposure (like vermiculite insulation) carry different scheduled values than trusts tied to industrial-only manufacturers.

"I explain it to clients this way: the scheduled value is the full amount the trust would pay if it could. The payment percentage is how much of that full amount the trust can actually afford to pay today, while still protecting its future claimants. A 5% payment from the Johns-Manville Trust on a $1.2 million scheduled value isn't a small check—it's $61,000 from one trust. Multiply that across 8 or 10 trusts and you see why the system works." — Paul Danziger, Founding Partner, Danziger & De Llano

What Are the 4 Factors That Determine Payment Percentages?

Actuaries calculate the sustainable payment percentage for each trust by modeling four primary variables. Understanding these factors explains why payment rates differ so dramatically across trusts.

Factor 1: Remaining Trust Assets

The foundation of any payment percentage calculation is the trust's current asset base. This includes cash reserves from the original bankruptcy settlement, subsequent contributions from affiliated companies under the reorganization plan, and accumulated investment returns on those assets. The Johns-Manville Trust was initially funded with approximately $2.5 billion in 1988 and has since received additional contributions and investment returns—yet has distributed over $5.26 billion across more than 1 million claims, according to the Johns Manville Trust profile at WikiMesothelioma.

Trusts with smaller initial funding pools or higher-than-expected early claim volumes have less flexibility in their payment percentages. Trusts funded with stocks or other equity instruments face additional volatility as asset values fluctuate with market conditions.

Factor 2: Projected Future Claims Volume

The most technically complex component of payment percentage calculation is the actuarial projection of future claims. Asbestos trust actuaries must estimate: how many total claims the trust will receive over its entire lifetime (typically 40 to 50 years), the disease-severity distribution of those claims (what percentage will be mesothelioma versus asbestosis versus pleural disease), and the timing of those claims (when in the future will diagnosis rates peak and decline).

These projections rely on epidemiological models of asbestos-related disease incidence, historical claims data from the trust and from similar trusts, population exposure data based on the bankrupt company's product distribution, and medical literature on latency periods. A RAND Corporation analysis of asbestos trust claims found that actual claims volumes have repeatedly exceeded early actuarial projections at multiple major trusts, forcing successive payment rate reductions over time.

Factor 3: Historical Claims Experience

As a trust accumulates years of claims data, actuaries update their projections based on actual experience. If early claims data show more severe disease categories (more mesothelioma, fewer pleural plaques) than initial projections assumed, the actuaries revise their forward projections upward—which reduces the sustainable payment percentage. Conversely, if a trust's historical claims are less severe than projected, the payment percentage may be maintained or increased.

Trusts also monitor claim fraud patterns. The Government Accountability Office's audit of asbestos trust claims identified inconsistencies in some trusts' claims review processes and recommended enhanced verification procedures. Strengthened fraud controls implemented after this audit have helped preserve some trusts' asset bases.

Factor 4: Investment Return Assumptions

Trust assets are invested in diversified portfolios—typically including US Treasuries, corporate bonds, equities, and cash equivalents. The projected investment return on those assets is factored into the actuarial model: higher projected returns allow a higher payment percentage; lower returns require a more conservative rate. Prolonged low-interest-rate environments like those of the 2010s and early 2020s compressed investment returns for many trusts, contributing to payment percentage reductions at multiple funds during that period.

"What clients don't always grasp is that a payment percentage reduction isn't necessarily bad news for them personally—it means the trust is being prudent about protecting future claimants. A trust that cuts its rate today to stay solvent is still there for the patient who gets diagnosed in 2040. The worst outcome for any claimant is filing a valid claim and finding the fund is exhausted." — Paul Danziger, Founding Partner, Danziger & De Llano

How Do Payment Percentages Differ Across Major Trusts?

The Asbestos Trust Fund Quick Reference at WikiMesothelioma documents current payment percentages and scheduled values across major active trusts. The range reflects the dramatically different claims histories and asset bases of the companies that created each fund.

Johns-Manville Trust (JM Trust): The oldest and most heavily claimed asbestos trust, with approximately 5.1% payment percentage. Over 1 million claims filed since 1988. Despite its low percentage, the JM Trust is virtually universally applicable because Johns-Manville supplied asbestos products across nearly every industry and geographic market. Mesothelioma scheduled value: approximately $1.2 million.

Owens Corning/Fibreboard Trust: Covers exposure to Owens Corning insulation products and Fibreboard Corporation building materials. Payment percentage varies by disease category and claimant tier. Particularly relevant for construction workers who handled Owens Corning's AttiCat and other insulation products.

Pittsburgh Corning Trust: Covers exposure to UNIBESTOS and other Pittsburgh Corning industrial pipe insulation products. Primarily relevant for shipyard workers, chemical plant workers, and utility workers who used PC products in industrial applications.

USG Corporation Trust: Covers exposure to USG drywall compounds and building products containing asbestos. Relevant for plasterers, drywall installers, and construction tradespeople who used USG joint compound products.

W.R. Grace Trust: With over $3 billion in initial funding, covers both Zonolite attic insulation (vermiculite-based) and Grace building materials. The Grace Trust is particularly important for claims involving Libby, Montana vermiculite exposure and homeowners with Zonolite attic insulation. Its relatively large asset base compared to claims volume supports a higher payment percentage than many trusts.

How Do Individual vs. Expedited Review Affect Your Payment?

Each TDP offers two review pathways: expedited review and individual review. Understanding the difference can meaningfully increase total compensation.

Expedited Review: A streamlined process that pays a fixed percentage of the scheduled value without individualized assessment. Claims typically process within 90 to 120 days. Expedited review makes sense when documentation is straightforward and the scheduled value at the expedited level is acceptable. It provides faster payment but not necessarily the highest possible payment.

Individual Review: Allows the claimant to present additional evidence—work history affidavits, product identification records, co-worker testimony, occupational hygiene reports—to support payment at or above the full scheduled value. The Trust Fund Filing Guidance at WikiMesothelioma explains that individual review processing typically takes 6 to 18 months but can result in significantly higher payment for claimants with exceptional documented exposure, particularly to high-value products or at high-volume worksites.

Strategic use of expedited versus individual review across multiple trust fund claims is one of the key value-adds that an experienced mesothelioma attorney provides. Expediting claims at trusts where documentation is standard while pursuing individual review at trusts with strong product-specific evidence maximizes both speed and total recovery. Our asbestos trust fund guide explains this strategy in more detail, and our mesothelioma attorney directory connects patients with attorneys who specialize in multi-trust recovery maximization.

Why Do Some Trusts Pay More Than Others for the Same Disease?

Payment percentages vary across trusts even for identical diseases because each trust reflects the specific financial situation of the defunct company that created it. A manufacturer that went bankrupt early in the litigation wave—before mesothelioma claims peaked—often funded its trust more conservatively, leading to lower current payment rates. Manufacturers whose products caused a narrower range of exposures may face fewer total projected claims and can sustain higher percentages.

Additionally, the disease category definitions in each TDP are specific to that trust. "Mesothelioma" at one trust may require pathological confirmation by a specific tissue test; another trust may accept clinical diagnosis. "Asbestosis" may require ILO profusion scores at one trust but a physician affidavit at another. These definitional differences affect how many claims qualify at each payment tier, which in turn affects how the actuaries project future claims and set the payment percentage.

"The question isn't just 'what is this trust's payment percentage?' It's 'what is this trust's scheduled value for mesothelioma?' A trust paying 30% on a $300,000 scheduled value pays $90,000. A trust paying 10% on a $1 million scheduled value pays $100,000. You can't compare payment percentages across trusts without also comparing the scheduled values they're being applied to." — Paul Danziger, Founding Partner, Danziger & De Llano

What Should You Know About Future Payment Percentage Changes?

Payment percentages are dynamic. Trustees review rates annually and can adjust them based on updated actuarial projections. Historical trends show that payment percentages at the largest, most heavily claimed trusts have generally declined over time as claims volumes proved higher than originally projected.

However, some trusts have recently increased payment percentages when actual claims were lower than projected or when investment returns outperformed assumptions. The most recently filed trust fund claims do not necessarily receive lower payment rates than earlier claims—the rate applicable is the current rate at the time of payment, regardless of when the claim was filed.

For active mesothelioma patients, timing matters modestly in expedited review claims (which process in 90-120 days) and more significantly in individual review claims (6-18 months). A payment rate change during an individual review could affect the final payment amount. Experienced mesothelioma attorneys monitor trust rate announcements and advise on timing strategy accordingly.

References

1. Asbestos Trust Funds — WikiMesothelioma
2. Asbestos Trust Fund Quick Reference — WikiMesothelioma
3. Johns Manville Trust — WikiMesothelioma
4. Trust Fund Filing Guidance — WikiMesothelioma
5. Asbestos Injury Claims and the Asbestos Trust Funds — RAND Corporation
6. Bankruptcy Code Section 524(g) — Cornell Law School Legal Information Institute
7. Mesothelioma — National Cancer Institute
8. Asbestos and Cancer Risk — National Cancer Institute
9. Asbestos Toxicological Profile — Agency for Toxic Substances and Disease Registry
10. Malignant Mesothelioma — American Cancer Society
11. Asbestos Bankruptcy Trusts and Future Claims — RAND Corporation
12. Asbestos Bankruptcy Trust Claims — Government Accountability Office